Cited 73 times in
Suppressive Mechanism of Salmosin, a Novel Disintegrin in B16 Melanoma Cell Metastasis.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장양수 | - |
dc.date.accessioned | 2019-11-11T05:02:41Z | - |
dc.date.available | 2019-11-11T05:02:41Z | - |
dc.date.issued | 2000 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/171565 | - |
dc.description.abstract | We have previously reported that salmosin, a novel disintegrin, was isolated from Korean snake (Agkistrodon halys brevicaudus) venom and significantly inhibited solid tumor growth in mice by perturbation of tumor-specific angiogenesis via blocking alphavbeta3 integrin expressed on vascular endothelial cells. In this study, we investigated the functional specificity of salmosin in tumor cell metastasis. Recombinant salmosin expressed in E. coli that has the RGD sequence markedly inhibited both B16F10 melanoma cell adhesion to the extracellular matrix proteins as well as B16F10 melanoma cell invasion through Matrigel-coated filter. The inhibition by salmosin can be caused by blocking integrins expressed on the surface of B16F10 melanoma cells. Salmosin significantly inhibited the proliferation of B16F10 melanoma cells on the plate coated with collagen I in a dose-dependent manner. In vivo B16F10 melanoma experimental metastasis, salmosin showed remarkable significant inhibitory effect on lung tumor colonization in a concentration-dependent manner. These results clearly demonstrate that antimetastatic activity of salmosin resulted from blocking the integrin-mediated adherence and alphavbeta3 integrin-mediated proliferation of the melanoma cells. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | Biochemical and Biophysical Research Communications | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antineoplastic Agents/chemistry | - |
dc.subject.MESH | Antineoplastic Agents/pharmacology | - |
dc.subject.MESH | Antineoplastic Agents/therapeutic use | - |
dc.subject.MESH | Cell Adhesion/drug effects | - |
dc.subject.MESH | Cell Division/drug effects | - |
dc.subject.MESH | Collagen/metabolism | - |
dc.subject.MESH | Crotalid Venoms/chemistry | - |
dc.subject.MESH | Crotalid Venoms/genetics | - |
dc.subject.MESH | Crotalid Venoms/pharmacology* | - |
dc.subject.MESH | Crotalid Venoms/therapeutic use* | - |
dc.subject.MESH | Disintegrins/genetics | - |
dc.subject.MESH | Disintegrins/pharmacology* | - |
dc.subject.MESH | Disintegrins/therapeutic use* | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Drug Combinations | - |
dc.subject.MESH | Extracellular Matrix Proteins/metabolism | - |
dc.subject.MESH | Histocytochemistry | - |
dc.subject.MESH | Laminin/metabolism | - |
dc.subject.MESH | Lung Neoplasms/drug therapy | - |
dc.subject.MESH | Lung Neoplasms/pathology | - |
dc.subject.MESH | Lung Neoplasms/secondary | - |
dc.subject.MESH | Melanoma, Experimental/drug therapy* | - |
dc.subject.MESH | Melanoma, Experimental/metabolism | - |
dc.subject.MESH | Melanoma, Experimental/pathology* | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred C57BL | - |
dc.subject.MESH | Neoplasm Invasiveness | - |
dc.subject.MESH | Neoplasm Transplantation | - |
dc.subject.MESH | Oligopeptides/analysis | - |
dc.subject.MESH | Peptide Fragments/chemistry | - |
dc.subject.MESH | Peptide Fragments/pharmacology | - |
dc.subject.MESH | Peptide Fragments/therapeutic use | - |
dc.subject.MESH | Proteoglycans/metabolism | - |
dc.subject.MESH | Receptors, Vitronectin/antagonists & inhibitors | - |
dc.subject.MESH | Receptors, Vitronectin/metabolism | - |
dc.subject.MESH | Recombinant Proteins/chemistry | - |
dc.subject.MESH | Recombinant Proteins/pharmacology | - |
dc.subject.MESH | Recombinant Proteins/therapeutic use | - |
dc.subject.MESH | Tumor Cells, Cultured | - |
dc.title | Suppressive Mechanism of Salmosin, a Novel Disintegrin in B16 Melanoma Cell Metastasis. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | In-Cheol Kang | - |
dc.contributor.googleauthor | Doo-Sik Kim | - |
dc.contributor.googleauthor | Yangsoo Jang | - |
dc.contributor.googleauthor | Kwang-Hoe Chung | - |
dc.identifier.doi | 10.1006/bbrc.2000.3130 | - |
dc.contributor.localId | A03448 | - |
dc.relation.journalcode | J00281 | - |
dc.identifier.eissn | 1090-2104 | - |
dc.identifier.pmid | 10944460 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0006291X00931309 | - |
dc.subject.keyword | disintegrin | - |
dc.subject.keyword | salmosin | - |
dc.subject.keyword | tumor metastasis | - |
dc.subject.keyword | snake venom | - |
dc.contributor.alternativeName | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | 장양수 | - |
dc.citation.volume | 275 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 169 | - |
dc.citation.endPage | 173 | - |
dc.identifier.bibliographicCitation | Biochemical and Biophysical Research Communications, Vol.275(1) : 169-173, 2000 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.